ErVimmune | $19,917,795 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Certified by Founder
Lodge
Passkey Therapeutics
start up
United States
- Cambridge, MA
- 22/10/2024
- Seed
- $20,000,000
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
- Industry Biotechnology Research
- Website https://passkeytx.com/
- LinkedIn https://www.linkedin.com/company/passkey-therapeutics/
Related People
Bruce BeutelCo Founder
United States -
Greater Boston
Leadership experience in novel therapeutics and platform research, business development, and company creation. Focused on strategy, vision, team building and value creation at the interface of science and business, particularly for seed through Series A stage biotech.
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Jetson(CANADA) | $50,000,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Infinitopes | $15,400,000 | (Jan 21, 2026)
Cosmos | $15,000,000 | (Jan 21, 2026)